Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3)
Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors
Scangarella-Oman NE
CAS Number: 1621-56-3
It inhibits Ack1 and germinal center kinase (GCK)
Moxifloxacin hydrochloride 60076 a new potential PET agentMoxifloxacin is a fourth generation synthetic fluoroquinolone antibacterial agent. Its antibacterial spectrum includes enteric Gram () rods (Escherichia coli, Proteus species, Klebsiella species), Haemophilus influenzae, atypical bacteria (Mycoplasma, Chlamydia, Legionella), and Streptococcus pneumoniae, and anaerobic bacteria. It differs from earlier antibacterials of the fluoroquinolone class such as levofloxacin and ciprofloxacin in having greater